No loopholes in tobacco health risks

By ACSH Staff — Nov 22, 2011
New York City s roll-your-own (RYO) cigarette shops are getting attention due to the city s attempt to end what they deem illicit tax avoidance by the RYO makers. At issue is the tax loophole that such businesses happily exploit: The loose tobacco they sell for their high-speed cigarette rolling machines is subject to only a fraction of the taxes that would be fixed on a commercially produced pack.

New York City s roll-your-own (RYO) cigarette shops are getting attention due to the city s attempt to end what they deem illicit tax avoidance by the RYO makers. At issue is the tax loophole that such businesses happily exploit: The loose tobacco they sell for their high-speed cigarette rolling machines is subject to only a fraction of the taxes that would be fixed on a commercially produced pack.

No Rx for ailing drug industry

By ACSH Staff — Nov 22, 2011
The pharmaceutical industry has been struggling. How bad is it? A report on Monday from Deloitte and Thompson Reuters reveals that investment returns from the research and development (R&D) of new drugs have fallen nearly 30 percent in the last year alone.

The pharmaceutical industry has been struggling. How bad is it? A report on Monday from Deloitte and Thompson Reuters reveals that investment returns from the research and development (R&D) of new drugs have fallen nearly 30 percent in the last year alone.

Fewer people dying from HIV, more people living with it

By ACSH Staff — Nov 22, 2011
Treatment for HIV-infected patients is more effective than ever before, the United Nations AIDS program (UNAIDS) has just reported. Thus, while the number of new HIV infections worldwide is over 20 percent lower than during the peak of the epidemic, as countries become more successful at keeping these patients alive, more people than ever are living with the virus: 34 million in 2010.

Treatment for HIV-infected patients is more effective than ever before, the United Nations AIDS program (UNAIDS) has just reported. Thus, while the number of new HIV infections worldwide is over 20 percent lower than during the peak of the epidemic, as countries become more successful at keeping these patients alive, more people than ever are living with the virus: 34 million in 2010.

Whistle blown on milk thistle supplement

By ACSH Staff — Nov 22, 2011
A study just presented at the annual meeting of the American Association for the Study of Liver Diseases has found that, despite its popularity, milk thistle extract provides no benefit for hepatitis C patients. A randomized trial from the University of North Carolina found that milk thistle (also known as the botanical compound silymarin) was no better than a placebo at improving liver function.

A study just presented at the annual meeting of the American Association for the Study of Liver Diseases has found that, despite its popularity, milk thistle extract provides no benefit for hepatitis C patients. A randomized trial from the University of North Carolina found that milk thistle (also known as the botanical compound silymarin) was no better than a placebo at improving liver function.

Unregulated, ineffective...and maybe dangerous

By ACSH Staff — Nov 22, 2011
Taking herbal supplements, we ve often observed, is rarely a great idea. Not only do they lack the efficacy of FDA-approved medications, but they re unregulated and can actually be dangerous. Patients suffering from chronic kidney disease, for instance, are particularly susceptible to a host of adverse effects from many approved pharmaceuticals. This is even more of a danger with herbal supplements, whose exact ingredients and dosages are often unknown.

Taking herbal supplements, we ve often observed, is rarely a great idea. Not only do they lack the efficacy of FDA-approved medications, but they re unregulated and can actually be dangerous. Patients suffering from chronic kidney disease, for instance, are particularly susceptible to a host of adverse effects from many approved pharmaceuticals. This is even more of a danger with herbal supplements, whose exact ingredients and dosages are often unknown.

Soy silly: From the department of nutritional trivia

By ACSH Staff — Nov 21, 2011
In other nonsense news, a study published in the American Journal of Clinical Nutrition finds that people who eat a lot of unfermented soy products, such as tofu or soy milk, have a 23 percent lower risk of lung cancer than those who eat the least amount. The results were obtained after researchers from the Shanghai Jiaotong University School of Medicine pooled findings from 11 observational studies.

In other nonsense news, a study published in the American Journal of Clinical Nutrition finds that people who eat a lot of unfermented soy products, such as tofu or soy milk, have a 23 percent lower risk of lung cancer than those who eat the least amount. The results were obtained after researchers from the Shanghai Jiaotong University School of Medicine pooled findings from 11 observational studies.

Some trash talk about cleaning products

By ACSH Staff — Nov 21, 2011
Yet another previously unknown anti-chemical environmental group has issued a scare screed alleging that hidden toxic chemicals in various household cleaning products may be poisoning us without our knowledge.

Yet another previously unknown anti-chemical environmental group has issued a scare screed alleging that hidden toxic chemicals in various household cleaning products may be poisoning us without our knowledge.

Up-close and personal, as well as online, can help counter obesity

By ACSH Staff — Nov 21, 2011
Two studies on obesity just published in the New England Journal of Medicine both found that primary care physicians (PCPs) can deliver safe and effective weight-loss interventions.

Two studies on obesity just published in the New England Journal of Medicine both found that primary care physicians (PCPs) can deliver safe and effective weight-loss interventions.

The Avastin decision: Science, emotion, and politics collide

By ACSH Staff — Nov 21, 2011
After an FDA advisory panel unanimously voted in June to revoke the approval of the drug Avastin as a treatment for advanced breast cancer, FDA commissioner Dr. Margaret A. Hamburg announced last week that the agency will support the committee s recommendation and rescind approval.

After an FDA advisory panel unanimously voted in June to revoke the approval of the drug Avastin as a treatment for advanced breast cancer, FDA commissioner Dr. Margaret A. Hamburg announced last week that the agency will support the committee s recommendation and rescind approval.